Kees Brinkman

12.1k total citations · 3 hit papers
139 papers, 6.0k citations indexed

About

Kees Brinkman is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Kees Brinkman has authored 139 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Infectious Diseases, 50 papers in Epidemiology and 49 papers in Virology. Recurrent topics in Kees Brinkman's work include HIV/AIDS drug development and treatment (51 papers), HIV Research and Treatment (49 papers) and HIV/AIDS Research and Interventions (47 papers). Kees Brinkman is often cited by papers focused on HIV/AIDS drug development and treatment (51 papers), HIV Research and Treatment (49 papers) and HIV/AIDS Research and Interventions (47 papers). Kees Brinkman collaborates with scholars based in Netherlands, United States and United Kingdom. Kees Brinkman's co-authors include Peter Reiss, Jan Smeıtınk, David M. Burger, Johannes A. Romijn, Peter P. Koopmans, Ard van Sighem, Hadewych J. M. ter Hofstede, Frank de Wolf, Suzanne E. Geerlings and Colette Smit and has published in prestigious journals such as The Lancet, Annals of Internal Medicine and The Journal of Immunology.

In The Last Decade

Kees Brinkman

135 papers receiving 5.8k citations

Hit Papers

Mitochondrial toxicity in... 1998 2026 2007 2016 1999 1998 2015 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy
    1999 677 citations Kees Brinkman, Peter Reiss et al. profile →
  2. Adverse effects of reverse transcriptase inhibitors
    1998 671 citations Kees Brinkman, David M. Burger et al. AIDS profile →
  3. Future challenges for clinical care of an ageing population infected with HIV: a modelling study
    2015 619 citations Mikaëla Smit, Kees Brinkman et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Kees Brinkman 3.8k 2.4k 2.3k 1.7k 654 139 6.0k
Mallory D. Witt 2.7k 0.7× 1.7k 0.7× 1.6k 0.7× 1.7k 1.0× 469 0.7× 138 4.8k
Jan Gerstoft 4.8k 1.2× 3.1k 1.3× 3.6k 1.6× 3.0k 1.7× 558 0.9× 303 9.2k
Colleen Hadigan 2.8k 0.7× 4.7k 2.0× 2.3k 1.0× 1.2k 0.7× 372 0.6× 131 6.8k
Gitte Kronborg 2.6k 0.7× 2.2k 0.9× 1.7k 0.7× 2.2k 1.3× 258 0.4× 168 6.5k
Keith Henry 4.4k 1.2× 1.4k 0.6× 3.9k 1.7× 1.9k 1.1× 263 0.4× 135 7.2k
Colette Smith 3.7k 1.0× 1.6k 0.7× 1.6k 0.7× 2.8k 1.6× 502 0.8× 233 6.9k
David A. Cooper 5.5k 1.4× 1.4k 0.6× 4.4k 1.9× 1.6k 0.9× 633 1.0× 118 7.1k
Graeme Moyle 4.9k 1.3× 2.4k 1.0× 3.8k 1.6× 1.5k 0.8× 458 0.7× 217 6.9k
Jennifer Hoy 5.3k 1.4× 2.8k 1.2× 3.2k 1.4× 2.9k 1.7× 357 0.5× 242 8.3k
Antonella Castagna 3.4k 0.9× 886 0.4× 2.5k 1.1× 1.5k 0.9× 346 0.5× 340 5.7k

Countries citing papers authored by Kees Brinkman

Since Specialization
Citations

This map shows the geographic impact of Kees Brinkman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kees Brinkman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kees Brinkman more than expected).

Fields of papers citing papers by Kees Brinkman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kees Brinkman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kees Brinkman. The network helps show where Kees Brinkman may publish in the future.

Co-authorship network of co-authors of Kees Brinkman

This figure shows the co-authorship network connecting the top 25 collaborators of Kees Brinkman. A scholar is included among the top collaborators of Kees Brinkman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kees Brinkman. Kees Brinkman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stutterheim, Sarah E., Roy A. Willems, L. Elsenburg, et al.. (2025). Reducing internalized HIV stigma with Intervention Mapping: the design, implementation, and evaluation of RESET (RESilience and Empowerment Training). AIDS Care. 38(2). 242–262.
2.
Wit, Ferdinand W.N.M., Vita W. Jongen, Kees Brinkman, et al.. (2025). Earlier Initiation of Treatment Following HIV Acquisition Reduces Non-AIDS-defining Malignancy Risk. Clinical Infectious Diseases.
3.
Vanhommerig, Joost W., Nienke Langebeek, Elisabeth H. Gisolf, et al.. (2024). De‐simplifying antiretroviral therapy from a single‐tablet to a two‐tablet regimen: Acceptance, patient‐reported outcomes, and cost savings in a multicentre study. HIV Medicine. 25(9). 1019–1029. 2 indexed citations
4.
Geers, Daryl, Rory D. de Vries, Corine H. GeurtsvanKessel, et al.. (2024). Immunogenicity of a bivalent BA.1 COVID-19 booster vaccine in people with HIV in the Netherlands. AIDS. 38(9). 1355–1365. 2 indexed citations
5.
Jansen, R.W.M.M., Joris R. de Groot, Martin E W Hemels, et al.. (2023). Does atrial fibrillation affect prognosis in hospitalised COVID-19 patients? A multicentre historical cohort study in the Netherlands. BMJ Open. 13(12). e071137–e071137. 3 indexed citations
6.
7.
8.
Prins, Jan M., Kees Brinkman, Eliane M.S. Leyten, et al.. (2022). Testing and healthcare seeking behavior preceding HIV diagnosis among migrant and non-migrant individuals living in the Netherlands: Directions for early-case finding. PLoS ONE. 17(3). e0264435–e0264435. 5 indexed citations
9.
Daas, Chantal den, Guido E.L. van den Berk, Peter Verboon, et al.. (2021). Role of Self-Stigma in Pathways from HIV-Related Stigma to Quality of Life Among People Living with HIV. AIDS Patient Care and STDs. 35(6). 231–238. 42 indexed citations
10.
Wit, Ferdinand W.N.M., Casper Rokx, Eliane M.S. Leyten, et al.. (2019). Immune reconstitution inflammatory syndrome in HIV infected late presenters starting integrase inhibitor containing antiretroviral therapy. EClinicalMedicine. 17. 100210–100210. 22 indexed citations
11.
Coul, Eline Op de, Ard van Sighem, Kees Brinkman, et al.. (2016). Factors associated with presenting late or with advanced HIV disease in the Netherlands, 1996–2014: results from a national observational cohort. BMJ Open. 6(1). e009688–e009688. 70 indexed citations
12.
Smit, Colette, Ard van Sighem, Peter Reiss, et al.. (2015). Impact of HIV care facility characteristics on the cascade of care in HIV-infected patients in the Netherlands. AIDS. 30(2). 301–310. 10 indexed citations
13.
Smit, Mikaëla, Colette Smit, Suzanne E. Geerlings, et al.. (2013). Changes in First-Line cART Regimens and Short-Term Clinical Outcome between 1996 and 2010 in The Netherlands. PLoS ONE. 8(9). e76071–e76071. 11 indexed citations
14.
Grijsen, Marlous L., Radjin Steingrover, Ferdinand W N M Wit, et al.. (2012). No Treatment versus 24 or 60 Weeks of Antiretroviral Treatment during Primary HIV Infection: The Randomized Primo-SHM Trial. PLoS Medicine. 9(3). e1001196–e1001196. 65 indexed citations
15.
Burger, David M., Patricia W. H. Hugen, Peter Reiss, et al.. (2003). Therapeutic drug monitoring of nelfinavir and indinavir in treatment-naive HIV-1-infected individuals. AIDS. 17(8). 1157–1165. 119 indexed citations
16.
Termaat, Rose-Marie, Kees Brinkman, F. Van Gompel, et al.. (1990). Cross-reactivity of monoclonal anti-DNA antibodies with heparan sulfate is mediated via bound DNA/histone complexes. Journal of Autoimmunity. 3(5). 531–545. 75 indexed citations
17.
Brinkman, Kees, Rose-Marie Termaat, Jo H. M. Berden, & Ruud J.T. Smeenk. (1990). Anti-DNA antibodies and lupus nephritis: the complexity of crossreactivity. Immunology Today. 11(7). 232–234. 78 indexed citations
18.
Termaat, Rose-Marie, et al.. (1990). Anti-heparan sulphate reactivity in sera from patients with systemic lupus erythematosus with renal or non-renal manifestations. Clinical & Experimental Immunology. 82(2). 268–274. 32 indexed citations
19.
Berden, Jo H. M., Rose-Marie Termaat, Kees Brinkman, et al.. (1989). Binding of anti-DNA antibodies to glomerular heparan sulfate: a new clue for the pathogenesis of SLE nephritis?. PubMed. 10(3). 127–32. 9 indexed citations
20.
Smeenk, R J, et al.. (1988). Reaction patterns of monoclonal antibodies to DNA.. The Journal of Immunology. 140(11). 3786–3792. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mallory D. Witt Breakdown of academic impact, for papers by Jan Gerstoft Breakdown of academic impact, for papers by Colleen Hadigan Breakdown of academic impact, for papers by Gitte Kronborg Breakdown of academic impact, for papers by Keith Henry Breakdown of academic impact, for papers by Colette Smith Breakdown of academic impact, for papers by David A. Cooper Breakdown of academic impact, for papers by Graeme Moyle Breakdown of academic impact, for papers by Jennifer Hoy Breakdown of academic impact, for papers by Antonella Castagna
Rankless by CCL
2026